Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) used for the relief of mild to moderate pain, including menstrual pain [1]. Its patent status and exclusivity details are a key concern for its market presence and the potential for generic competition.
When Does Mefenamic Acid Patent Protection End?
The original patents for mefenamic acid have long expired [2]. The compound itself was patented in the late 1950s and approved for medical use shortly thereafter. This means that the active pharmaceutical ingredient (API) itself is no longer protected by its foundational patents. However, specific formulations, manufacturing processes, or new therapeutic uses could potentially have had their own, more recent patent protections. Information on specific, active patents for mefenamic acid can be tracked through resources like DrugPatentWatch.com [2].
What About Mefenamic Acid Exclusivity Periods?
Beyond patent expiry, drugs can benefit from regulatory exclusivity periods granted by agencies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). These exclusivity periods are separate from patent rights and can prevent generic or biosimilar approval for a certain number of years, even if patents have expired. For mefenamic acid, as an older drug with long-expired patents, any remaining regulatory exclusivity would also have concluded.
Can Generic Mefenamic Acid Be Manufactured?
Yes, generic versions of mefenamic acid are available on the market. The expiry of its primary patents and any associated regulatory exclusivity periods allows other pharmaceutical companies to produce and sell their own versions of the drug, typically at a lower cost [2].
How Does Mefenamic Acid Work?
Mefenamic acid functions as an NSAID by inhibiting the activity of cyclooxygenase (COX) enzymes. These enzymes are responsible for the production of prostaglandins, which are chemicals in the body that promote inflammation, pain, and fever [1]. By blocking prostaglandin synthesis, mefenamic acid reduces these symptoms.
What Are the Uses of Mefenamic Acid?
Mefenamic acid is primarily prescribed for the short-term treatment of acute pain, particularly menstrual pain (dysmenorrhea) [1]. It is also used for other types of mild to moderate pain, such as dental pain or pain associated with muscular and joint disorders.
What Are the Side Effects of Mefenamic Acid?
Common side effects associated with mefenamic acid include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain [1]. More serious, though less common, side effects can include stomach ulcers, bleeding, kidney problems, and allergic reactions.
What Are the Risks of Taking Mefenamic Acid?
Like other NSAIDs, mefenamic acid carries risks, especially with prolonged use or in individuals with pre-existing conditions. These risks include gastrointestinal bleeding and perforation, cardiovascular events (heart attack and stroke), and renal impairment [1]. Patients with a history of ulcers, kidney disease, or heart disease should use mefenamic acid with caution and under medical supervision.
Who Makes Mefenamic Acid?
Mefenamic acid is manufactured by various pharmaceutical companies worldwide. Both branded versions and generic formulations are available, with different manufacturers holding licenses for production and distribution.
Sources:
[1] https://www.nhs.uk/medicines/mefenamic-acid/
[2] https://drugpatentwatch.com/